Press Play (company)
Press Play was a Danish video game development company known for creating innovative and engaging games. The company was founded in 2006 by Rune Dittmer, Mikkel Thorsted, and Ole Teglbjærg. Press Play gained recognition for its unique approach to game design and its ability to create compelling gameplay experiences.
History
Press Play was established in Copenhagen, Denmark, with the goal of developing high-quality video games. The founders, Rune Dittmer, Mikkel Thorsted, and Ole Teglbjærg, brought together their expertise in game development to create a studio that focused on creativity and innovation.
In 2012, Press Play was acquired by Microsoft Studios, which provided the company with additional resources and support to develop new titles. This acquisition allowed Press Play to reach a wider audience and further establish its reputation in the gaming industry.
Notable Games
Press Play is best known for several notable games, including:
- Max: The Curse of Brotherhood - An action-adventure game that follows the story of a young boy named Max who embarks on a journey to rescue his kidnapped brother. The game features a unique drawing mechanic that allows players to manipulate the environment to solve puzzles.
- Kalimba - A puzzle-platformer game that challenges players to control two totem pieces simultaneously, navigating through intricate levels filled with obstacles and enemies.
Closure
Despite its success, Press Play faced challenges in the competitive gaming market. In 2016, Microsoft announced the closure of Press Play as part of a restructuring effort. The closure marked the end of a decade-long journey for the company, but its games continue to be enjoyed by players around the world.
Legacy
Press Play's legacy lives on through its innovative games and the impact it had on the gaming industry. The company's commitment to creativity and quality has left a lasting impression on both players and developers.
Related Pages
Categories
This article is a video game–related stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD